The MD-6000 Bladder Scanner is a non-invasive diagnostic tool that measures the amount of urine in the bladder or used to determine how much urine remains in the bladder after urination as a way to ...
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin alfa ...
Apr. 5, 2026 Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results